Corporate identity provides unified front through UK biotech consolidation

Following the high profile merger between British Biotech, RiboTargets and Vernalis, a priority was placed on creating a strong corporate identity for the new company, Vernalis plc, that would strengthen the Company and project a unified image to the market.

Northbank was commissioned to create and implement the corporate identity, building on the existing relationship with RiboTargets. Northbank had created a strong, clean and memorable identity for RiboTargets and the view of Vernalis' CEO was that the existing image already communicated many of the Company's values. Therefore the decision was made to develop this identity to represent the growth, combined strengths, vision and outlook of the new entity.

Simon Sturge, Vernalis' CEO, commented, "It was important for us to retain some consistency through the mergers, not forgetting our heritage or the reputations we had built up for good science and commercial acumen. So the corporate identity provided us with an ideal opportunity to make an important inroad into company integration."

With this in mind, Northbank's designers captured the personality of the new Company, whilst sustaining characteristics from both the Vernalis and RiboTargets logos, which were merged naturally to accompany the retained name of Vernalis.

"The project provided us with an exciting opportunity to build on an identity which has achieved good recognition within the market", noted Chris Fisher, Creative Director at Northbank. Chris continued, "It's rewarding to retain a long term relationship with a client as they evolve and to continue our support as their communication needs change."

Vernalis' new identity was launched at the start of October 2003, including the new website www.vernalis.com and is now being rolled out to further projects.

View case study

back to news

© 2007 College Hill Associates | Registered in England No 1036926 / VAT No 245666930 | Legal